Literature DB >> 28921579

Material basis studies of anti-Influenza A active ingredients in Tanreqing Injection.

Haiyan Zhu1, Mingcang Chen2, Xunlong Shi1, Chenchen Shi1, Chenggang Huang2.   

Abstract

Tanreqing Injection (TRQ) has been used primarily in treating infections of the upper respiratory tract and serious influenza in China, as a classical compound herbal recipe. TRQ had been demonstrated to have effects of clearing heat, eliminating phlegm, detoxification, reducing inflammation and alleviating cough. The survival rate, histopathology of lungs and viral titers in mice were evaluated in this study to verify the curative effect of TRQ. However, there is not enough information about the components. In the present study, a high-performance and practical LC/QTOF/MS method was developed for characterization and identification of the natural ingredients in TRQ. A total of 60 compounds, including 10 amino acids, 10 iridoid glucosides, 14 flavonoids, 13 other phenolic compounds, 10 steroid acids and three other compounds, were characterized and identified. We also confirmed the material basis of anti-Influenza A active ingredients in TRQ. Therefore, we have developed an accurate analytical method. LC/QTOF/MS could be applied for identification the complex components in traditional Chinese medicine.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Influenza A virus; LC/QTOF/MS; Tanreqing Injection; antiviral research; component analysis

Mesh:

Substances:

Year:  2017        PMID: 28921579     DOI: 10.1002/bmc.4097

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  4 in total

Review 1.  Chinese herbal injections for coronavirus disease 2019 (COVID-19): A narrative review.

Authors:  Xiao-Bin Zhu; Meng Guo; Zhi-Hui Zhang; Li-Hua Sun; Lei Liu; Li-Juan Zhou; Chun-Lei Shan; Yi Yang; Lian-Di Kan; Liu-Cheng Li
Journal:  Integr Med Res       Date:  2021-09-30

2.  Efficacy and safety of Tanreqing oral liquid in treatment of acute bronchitis: study protocol for a randomized controlled trial.

Authors:  Guilan Cheng; Bin She; Bing Mao; Hongli Jiang
Journal:  Trials       Date:  2022-05-07       Impact factor: 2.728

3.  Traditional Chinese Medicine Injections Combined With Oseltamivir for Influenza: Systematic Review and Network Meta-Analysis.

Authors:  Yingying Peng; Zhe Chen; Huanmin Li; Yaowei Han; Dan Sun; Yanjiao Li; Xiaoxia Wu; Hongxiang Chen; Xinmin Li
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 4.  The therapeutic effects of traditional chinese medicine on COVID-19: a narrative review.

Authors:  Can Wang; Shusen Sun; Xuansheng Ding
Journal:  Int J Clin Pharm       Date:  2020-09-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.